RK-4
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction (NCT07203521) | Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd | 2025-11-01 |
| RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction (NCT07166380) | Neurodawn Pharmaceutical Co., Ltd. | 2025-09-20 |
Track RK-4 automatically
Every clearance here is in the API, with alerts when new ones post.